| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Mucosal Immunity Section, Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResults and DiscussionDisclosuresReferences |
|---|
together with IL-6 induce the differentiation of IL-17-producing T cells (Th17) T cells. We therefore examined whether CD4+CD25+Foxp3+ regulatory T cells, i.e., cells previously shown to produce TGF-, serve as Th17 inducers. We found that upon activation purified CD25+ T cells (or sorted GFP+ T cells obtained from Foxp3-GFP knockin mice) produce high amounts of soluble TGF- and when cultured with CD4+CD25–Foxp3– T cells in the presence of IL-6 induce the latter to differentiate into Th17 cells. Perhaps more importantly, upon activation, CD4+CD25+Foxp3+(GFP+) T cells themselves differentiate into Th17 cells in the presence of IL-6 (and in the absence of exogenous TGF-). These results indicate that CD4+CD25+Foxp3+ regulatory T cells can function as inducers of Th17 cells and can differentiate into Th17 cells. They thus have important implications to our understanding of regulatory T cell function and their possible therapeutic use. |
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResults and DiscussionDisclosuresReferences |
|---|
and IL-6, acting in concert, induced the differentiation of naive T cells into Th17 cells capable of IL-17 production (1, 2). Because CD4+CD25+Foxp3+"natural" regulatory T cells (Treg)2 express cell surface or secrete TGF-, this introduces the possibility that Tregs may be playing a role in such differentiation (3, 4, 5). Indeed, in previous studies it was shown that Tregs do serve as a source of TGF- for Th17 development in vitro, but it was implied that this role is more usually subserved by APCs in vivo. Here we show that upon activation Tregs produced high amounts of TGF- and with the addition of IL-6 induce CD4+CD25–Foxp3– T cells to differentiate into IL-17-producing cells (in the absence of other cells). Perhaps more importantly, we show that activated Tregs themselves differentiate into IL-17-producing cells in the presence of a source of IL-6. These results reveal that CD4+CD25+Foxp3+ T cells have dual effects on the course of an immune response. |
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResults and DiscussionDisclosuresReferences |
|---|
Specific pathogen-free, female C57BL/6 mice were purchased from The Jackson Laboratory. Foxp3-IRES-GFP knock-in mice on C57BL/6 background (1) were provided by Dr. Mohamed Oukka (Harvard Medical School). The mice were studied at 8–14 wk of age. Animal use adhered to National Institutes of Health Laboratory Animal Care Guidelines.
T cell purification
Splenocytes from Foxp3-GFP knock-in mice were incubated with CD4 microbeads and then positively selected through LS columns (Miltenyi Biotec). Enriched CD4+ cells were then FACS-sorted into GFP+ and GFP– cells. The purities of both subpopulations were always >99.5%. CD4+CD25+ and CD4+CD25– T cells were purified as previously described (3, 4).
Generation of bone marrow-derived dendritic cells (DC)
A total of 5 x 106 bone marrow cells were cultured in 10 ml of culture medium containing 20 ng/ml GM-CSF. On days 2–3 of culture, nonadherent granulocytes were removed and GM-CSF medium replaced. Loosely adherent cells were transferred to a fresh dish on day 6, collected on day 7 followed by further incubation with CD11c microbeads and then positively selected through MS columns (Miltenyi Biotec).
In vitro cell stimulation
The culture medium used was IMDM supplemented with 10% FCS, 100 U/ml penicillin, 100 µg/ml streptomycin, and 5 x 10–3 M mercaptoethanol. Cells were cultured in 2 ml volume with plate-bound anti-CD3 (10 µg/ml), soluble anti-CD28 (2 µg/ml). Cytokines and neutralizing Abs were added at the following concentrations: 3 ng/ml rTGF-1 (R&D Systems), 20 ng/ml IL-6 (PeproTech), 10 ng/ml IL-12 (PeproTech), 10 µg/ml anti-IL4 (BD Pharmingen). ALK5 inhibitor were added at 2.5 µM. Preactivated CD4+CD25+ cells or GFP+ cells were prepared as previously described (4). In some cases, purified CD4+CD25– T cells were labeled with CFSE (molecular probe) before culture.
Intracellular cytokine staining
Cells were restimulated with PMA/ionomycin (Sigma-Aldrich) and Golgiplug (BD Pharmingen) for 4 h. Cells were Fc blocked, stained with CD4 Alexa647 (BD Pharmingen), then fixed and permeabilized in cytofix/permeablization solution (BD Pharmingen) followed by labeling of IL-17 PE, IFN-
allophycocyanin (BD Pharmingen), or Foxp3 FITC (eBioscience) or incubated with biotinylated chicken anti-TGF- (R&D Systems) or biotinylated chicken IgY (Jackson ImmunoResearch Laboratories) followed by streptavidin-PE-Cy5 (BD Pharmingen).
Cytokine ELISA
IL-17 was assayed using IL-17 Duoset ELISA kit (R&D Systems) and active form TGF- (without acid treatment) or total TGF- (with acid treatment) using TGF-1 ELISA kit (Invitrogen Life Technologies).
|
Results and Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResults and DiscussionDisclosuresReferences |
|---|
In initial studies, we asked if CD4+CD25+Foxp3+ T cells can induce Th17 differentiation in the absence of APCs and/or exogenous TGF-. To address this question, we employed highly purified populations of Foxp3+ T cells by isolating GFP+ cells from the spleens of Foxp3-IRES-GFP knock-in mouse that express GFP only when the Foxp3 gene is transcriptionally active. As shown in Fig. 1A, coculture of fresh GFP+ (CD4+) T cells with GFP– (CD4+) T cells obtained by flow cytometric cell sorting led to the appearance of a low number of IL-17-positive cells at a 1:1 cell (GFP+/GFP–) ratio (1.8%) and a somewhat increased number of these cells at a 2:1 ratio (5.76%). In addition, as shown in Fig. 1C, at the latter ratio a substantial amount of IL-17 could be detected in the culture supernatant.
|
expression and TGF- secretion; we therefore determined the ability of pre-activated CD4+CD25+Foxp3+ (GFP+) T cells to induce Th17 differentiation. In these studies, we stimulated sorted GFP+ or GFP– T cells with anti-CD3/anti-CD28 for 48 h and then rested the stimulated cells in IL-2 for 24 h to minimize activation-induced cell death; we then cocultured the activated GFP+ or GFP– T cells with fresh GFP– T cells for 4 days in the presence of IL-6. As shown in Fig. 1A, coculture of activated CD4+Foxp3+ T cells with fresh CD4+Foxp3– T cells led to a cell population containing 
21% IL-17-producing cells, whereas coculture of activated CD4+Foxp3– T cells with CD4+Foxp3– T cells led to a cell population containing virtually no IL-17-producing cells. CD4+Foxp3– T cells stimulated with rTGF- (3 ng/ml) and IL-6, 12% of the cell population were IL-17-producing cells indicating that the Tregs were even more efficient than exogenous TGF- in inducing IL-17-producing cells. Finally, to rule out the possibility that the IL-17-producing cells came from the CD4+Foxp3– T cell population rather than from the CD4+Foxp3+ population that lost Foxp3 expression after stimulation with IL-6 (1) we labeled purified CD4+CD25– T cells with CFSE before coculture with CD4+CD25+ T cells activated as in the experiment above. As shown in Fig. 1B, we found that 26.8% of CFSE+ T cells were IL-17-producing cells after coculture of activated CD4+CD25+ T cells whereas only 2.41% of CFSE+ cells were IL-17-producing cells after coculture of activated CD4+CD25– T cells.
The induction of IL-17-producing cells by activated CD4+CD25+Foxp3+ T cells is TGF- dependent
To determine whether the differentiation of CD4+CD25–Foxp3– T cells into IL-17-producing cells induced by activated CD4+CD25+Foxp3+ T cells was TGF--dependent we next cultured cells in the presence or absence of a TGF-RI inhibitor, i.e., an inhibitor of the kinase activity of TGF-RI (ALK5) (4). Accordingly, we cultured activated CD4+CD25+ T cells with CD4+CD25– T cells labeled with CFSE as described above but in this case in the presence or absence of ALK5 inhibitor (2.5 µM/ml). As show in Fig. 2A, the addition of ALK5 inhibitor dramatically decreased the number of CFSE-positive IL-17-positive cells (from 26.93% to 3.04%) whereas it increased the number of IFN--producing cells (from 10.1% to 24.8%). Thus, the differentiation of IL-17-producing cells induced by activated CD4+CD25+ T cells does in fact require TGF- signaling.
|
to affect such differentiation we then measured both the active and total TGF- in the culture medium of the above described cocultures. As show in Fig. 2B, substantial amounts of TGF- (600 pg/ml) was detected in the culture supernatant obtained from cocultured activated CD4+CD25+Foxp3+ and CD4+CD25–Foxp3– T cells but not from the culture supernatant of cocultured activated CD4+CD25–Foxp3– and CD4+CD25–Foxp3– T cells. This TGF- is not coming from CD4+CD25–Foxp3– T cells after coculture with activated CD4+CD25+Foxp3+ T cells since activated CD4+CD25+Foxp3+ T cells produce a similar amount of TGF- when cultured alone. These results provide strong evidence that the induction of IL-17-producing cells by activated CD4+CD25+Foxp3+ cells was TGF- dependent. CD4+CD25+Foxp3+T cells themselves differentiate into IL-17-producing cells in the presence of IL-6
In further studies, we determined if CD4+CD25+Foxp3+ T cells themselves differentiate into IL-17-producing cells. Accordingly, we stimulated sorted CD4+CD25+ T cells or CD4+CD25– T cells alone with anti-CD3/anti-CD28 in the presence of IL-6 and then, after 6 days determined IL-17 expression. As shown in Fig. 3A, we found that the cultured CD4+CD25+ T cell population contained 10% IL-17-producing cells whereas the cultured CD4+CD25– T cells contained only 1% IL-17-producing cells. To exclude the possibility that the IL-17-producing cells arose from Foxp3– cells in the CD25+ cell population we next conducted studies of FACS-sorted CD4+GFP+ cells from Foxp3 knock-in mice since in this case we could be certain that the cells were in fact Foxp3 positive at the initiation of the study. As shown in Fig. 3B, we found that IL-17-producing T cells were detected as early as day 3 (3%), and were optimally expressed at day 4 or day 6 when 17% and 20% of the cells were IL-17-producing cells, respectively. Of interest, the percentages of both IL-17 single-positive and GFP/IL-17 double-positive cells increase during the culture period, suggesting that Foxp3-positive cells can coexpress IL-17 and that IL-17 single-positive cells pass through an Foxp3/IL-17 double-positive stage. Finally, we subjected sorted GFP+ and GFP– cells to polarization under Th1 conditions and, as shown in Fig. 3B, found that whereas GFP+ cells could not be induced to become IFN- producing cells, GFP– cells developed into IFN--producing cells at a high rate. Thus, CD4+Foxp3+ cells can undergo self-induced Th17 differentiation, but resist Th1 differentiation.
|
and IL-6; this was probably due to the low proliferation and expansion rate of GFP+ cells compared with GFP– cells after stimulation. These converted IL-17-producing cells exhibited a stable phenotype after culture for 14 days or after a second round of stimulation in the absence of exogenous IL-6 (data not shown). Differentiation of IL-17-producing cells from CD4+CD25+Foxp3+ T cells in the coculture of DCs in response to TLR ligation
To determine whether Tregs can differentiate into IL-17-producing T cells after the interaction with stimulated DCs rather than exogenous IL-6 we cocultured sorted CD4+GFP+ (Foxp3+) cells with bone marrow-derived DCs in the presence of LPS a TLR4 ligand. The proliferation and expansion of CD4+ GFP+ (Foxp3+) cells in such cultures was poor, probably due to the lack of IL-2 (6). Nevertheless, as shown in Fig. 4A, a small number of IL-17-producing cells were generated under these conditions.
|
in these cultures by intracellular staining with anti-TGF-. As shown in Fig. 4B, the GFP+ regulatory T cells contained a subpopulation of TGF--containing cells that was larger and more intensely stained than that in GFP– (CD4+) T cells. In addition, the DC population also contained a TGF--positive subpopulation when cocultured with GFP– T cells but this was greatly augmented when these cells were cocultured with GFP+ T cells. Thus, regulatory T cells augment the induction of IL-17-producing cells in two ways: they produce TGF- themselves and they induce DCs to produce increased amounts of TGF-.
The data reported above indicate that CD4+CD25+Foxp3+ regulatory T cells can either induce other cells to differentiate into Th17 cells or to induce themselves to undergo such differentiation. However, they provide little information about the quantitative importance of this differentiation pathway and it remains possible (or even probable) that other cells, such as activated APCs are the main source of TGF- necessary for Th17 differentiation and that most Th17 cells do not arise from regulatory T cells. Recently, it has been shown that in a graft-vs-host disease model in which IL-17 is the predominant cytokine, the provision of regulatory T cells favors the development of an increased percentage of IL-17-producing cells given early (7). In addition, it has been shown that Foxp3+ cells are increased in human inflammatory lesions of the gastrointestinal tract including Crohn’s disease (8). These findings are compatible with the data reported here and suggest that Tregs do in fact induce the differentiation of Th17 cells under in vivo conditions. However, additional studies are necessary to prove this point.
Regardless of its quantitative significance, the fact that this differentiation pathway exists at all has certain implications. One implication is that the repertoire of the regulatory T cell may need to be expanded to include its conversion into IL-17-producing cells and the production of IL-17, particularly in settings where IL-17 mediates certain homeostatic functions rather than proinflammatory effect functions (9). A possible example of this is the recent finding that in the gastrointestinal tract, IL-17 has been shown to promote epithelial barrier function by stimulating tight junction protein and antimicrobial peptides expression and mucin secretion (10, 11). Another and perhaps more important implication is that treatment of autoimmune states by administration of regulatory T cells can, through conversion to IL-17-producting cells, lead to increased rather than decreased inflammation. This did not seem to be the case in a recent study in which it was found that provision of regulatory T cells ameliorated established cell transfer colitis (12). On the other hand, we found in preliminary studies that mice develop a more severe trinitrobenzene sulfonic acid-colitis accompanied by increased IL-17 production when existing colitis is accompanied by administration of regulatory T cells (data not shown). Thus it is obvious that additional work will be necessary to clarify this issue.
|
Acknowledgments |
|---|
|
Disclosures |
|---|
|
TopAbstractIntroductionMaterials and MethodsResults and DiscussionDisclosuresReferences |
|---|
|
Footnotes |
|---|
1 Address correspondence and reprint requests to Dr. Warren Strober, Mucosal Immunity Section, Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Clinical Research Center, Room 5W3940, 10 Center Drive, Bethesda, MD 20892. E-mail: wstrober{at}niaid.nih.gov 
2 Abbreviations used in this paper: Treg, regulatory T cell; Th17, IL-17- producing cells; DC, dendritic cell.
Received for publication January 7, 2007. Accepted for publication April 2, 2007.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResults and DiscussionDisclosuresReferences |
|---|
induces development of the T(H)17 lineage. Nature 441: 231-234. [Medline]. J. Exp. Med. 194: 629-644. -mediated suppression by CD4+CD25+ T cells is facilitated by CTLA-4 signaling. J. Immunol. 177: 2331-2339. initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat. Immunol. 7: 1151-1156. [Medline]This article has been cited by other articles:
|
|
 |
|
  G. Murugaiyan and B. Saha Protumor vs Antitumor Functions of IL-17 J. Immunol., October 1, 2009; 183(7): 4169 - 4175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. De Serres, M. H. Sayegh, and N. Najafian Immunosuppressive Drugs and Tregs: A Critical Evaluation! Clin. J. Am. Soc. Nephrol., October 1, 2009; 4(10): 1661 - 1669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Piconese, G. Gri, C. Tripodo, S. Musio, A. Gorzanelli, B. Frossi, R. Pedotti, C. E. Pucillo, and M. P. Colombo Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation Blood, September 24, 2009; 114(13): 2639 - 2648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Guerin, J. R. Prins, and S. A. Robertson Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum. Reprod. Update, September 1, 2009; 15(5): 517 - 535. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Q. Tran, J. Andersson, R. Wang, H. Ramsey, D. Unutmaz, and E. M. Shevach GARP (LRRC32) is essential for the surface expression of latent TGF-{beta} on platelets and activated FOXP3+ regulatory T cells PNAS, August 11, 2009; 106(32): 13445 - 13450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Gounaris, N. R. Blatner, K. Dennis, F. Magnusson, M. F. Gurish, T. B. Strom, P. Beckhove, F. Gounari, and K. Khazaie T-Regulatory Cells Shift from a Protective Anti-Inflammatory to a Cancer-Promoting Proinflammatory Phenotype in Polyposis Cancer Res., July 1, 2009; 69(13): 5490 - 5497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Sharma, D.-Y. Hou, Y. Liu, P. A. Koni, R. Metz, P. Chandler, A. L. Mellor, Y. He, and D. H. Munn Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes Blood, June 11, 2009; 113(24): 6102 - 6111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. K. Hendrikx, E. A. F. J. van Gurp, W. M. Mol, W. Schoordijk, V. D. K. D. Sewgobind, J. N. M. IJzermans, W. Weimar, and C. C. Baan End-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T-cells Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1969 - 1978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ayyoub, F. Deknuydt, I. Raimbaud, C. Dousset, L. Leveque, G. Bioley, and D. Valmori Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the TH17 lineage-specific transcription factor ROR{gamma}t PNAS, May 26, 2009; 106(21): 8635 - 8640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Beriou, C. M. Costantino, C. W. Ashley, L. Yang, V. K. Kuchroo, C. Baecher-Allan, and D. A. Hafler IL-17-producing human peripheral regulatory T cells retain suppressive function Blood, April 30, 2009; 113(18): 4240 - 4249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. G. Evans, N. J. Gullick, S. Kelly, C. Pitzalis, G. M. Lord, B. W. Kirkham, and L. S. Taams In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses PNAS, April 14, 2009; 106(15): 6232 - 6237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nurieva, X. O. Yang, Y. Chung, and C. Dong Cutting Edge: In Vitro Generated Th17 Cells Maintain Their Cytokine Expression Program in Normal but Not Lymphopenic Hosts J. Immunol., March 1, 2009; 182(5): 2565 - 2568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chang, A. J. Lee, L. Fitzpatrick, M. Zhang, and S.-C. Sun NF-{kappa}B1 p105 Regulates T Cell Homeostasis and Prevents Chronic Inflammation J. Immunol., March 1, 2009; 182(5): 3131 - 3138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Siegmund, B. Ruckert, N. Ouaked, S. Burgler, A. Speiser, C. A. Akdis, and C. B. Schmidt-Weber Unique Phenotype of Human Tonsillar and In Vitro-Induced FOXP3+CD8+ T Cells J. Immunol., February 15, 2009; 182(4): 2124 - 2130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Komatsu, M. E. Mariotti-Ferrandiz, Y. Wang, B. Malissen, H. Waldmann, and S. Hori Heterogeneity of natural Foxp3+ T cells: A committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity PNAS, February 10, 2009; 106(6): 1903 - 1908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Chauhan, J. El Annan, T. Ecoiffier, S. Goyal, Q. Zhang, D. R. Saban, and R. Dana Autoimmunity in Dry Eye Is Due to Resistance of Th17 to Treg Suppression J. Immunol., February 1, 2009; 182(3): 1247 - 1252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Wang, H. D. Edington, U. N.M. Rao, D. M. Jukic, A. Radfar, H. Wang, and J. M. Kirkwood Effects of High-Dose IFN{alpha}2b on Regional Lymph Node Metastases of Human Melanoma: Modulation of STAT5, FOXP3, and IL-17 Clin. Cancer Res., December 15, 2008; 14(24): 8314 - 8320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Stritesky, N. Yeh, and M. H. Kaplan IL-23 Promotes Maintenance but Not Commitment to the Th17 Lineage J. Immunol., November 1, 2008; 181(9): 5948 - 5955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Shale and S. Ghosh Beyond TNF, Th1 and Th2 in inflammatory bowel disease Gut, October 1, 2008; 57(10): 1349 - 1351. [Full Text] [PDF]
|
|
|
|
|
|
H. J. P. M. Koenen, R. L. Smeets, P. M. Vink, E. van Rijssen, A. M. H. Boots, and I. Joosten Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells Blood, September 15, 2008; 112(6): 2340 - 2352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Andersson, D. Q. Tran, M. Pesu, T. S. Davidson, H. Ramsey, J. J. O'Shea, and E. M. Shevach CD4+FoxP3+ regulatory T cells confer infectious tolerance in a TGF-{beta}-dependent manner J. Exp. Med., September 1, 2008; 205(9): 1975 - 1981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Radhakrishnan, R. Cabrera, E. L. Schenk, P. Nava-Parada, M. P. Bell, V. P. Van Keulen, R. J. Marler, S. J. Felts, and L. R. Pease Reprogrammed FoxP3+ T Regulatory Cells Become IL-17+ Antigen-Specific Autoimmune Effectors In Vitro and In Vivo J. Immunol., September 1, 2008; 181(5): 3137 - 3147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Porrett, X. Yuan, D. F. LaRosa, P. T. Walsh, J. Yang, W. Gao, P. Li, J. Zhang, J. M. Ansari, W. W. Hancock, et al. Mechanisms Underlying Blockade of Allograft Acceptance by TLR Ligands J. Immunol., August 1, 2008; 181(3): 1692 - 1699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Reardon, A. Wang, and D. M. McKay Transient Local Depletion of Foxp3+ Regulatory T Cells during Recovery from Colitis via Fas/Fas Ligand-Induced Death J. Immunol., June 15, 2008; 180(12): 8316 - 8326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Zheng, J. Wang, and D. A. Horwitz Cutting Edge: Foxp3+CD4+CD25+ Regulatory T Cells Induced by IL-2 and TGF-{beta} Are Resistant to Th17 Conversion by IL-6 J. Immunol., June 1, 2008; 180(11): 7112 - 7116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-G. Chai, D. Coe, D. Chen, E. Simpson, J. Dyson, and D. Scott In Vitro Expansion Improves In Vivo Regulation by CD4+CD25+ Regulatory T Cells J. Immunol., January 15, 2008; 180(2): 858 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Glick, R. Perez-Lorenzo, and J. Mohammed Context-dependent regulation of cutaneous immunological responses by TGF{beta}1 and its role in skin carcinogenesis Carcinogenesis, January 1, 2008; 29(1): 9 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Noguchi, D. Wakita, M. Tajima, S. Ashino, Y. Iwakura, Y. Zhang, K. Chamoto, H. Kitamura, and T. Nishimura Blocking of IL-6 signaling pathway prevents CD4+ T cell-mediated colitis in a Th17-independent manner Int. Immunol., December 1, 2007; 19(12): 1431 - 1440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. De Luca, C. Montagnoli, T. Zelante, P. Bonifazi, S. Bozza, S. Moretti, C. D'Angelo, C. Vacca, L. Boon, F. Bistoni, et al. Functional yet Balanced Reactivity to Candida albicans Requires TRIF, MyD88, and IDO-Dependent Inhibition of Rorc J. Immunol., November 1, 2007; 179(9): 5999 - 6008. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
